Page last updated: 2024-08-18

pyrroles and Incontinentia Pigmenti Achromians

pyrroles has been researched along with Incontinentia Pigmenti Achromians in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Robert, C; Sibaud, V1
Brzezniak, C; Szabo, E1
Aranegui, B; Bueno, C; Espinosa Lara, P; Jiménez Reyes, J; Vargas-Machuca, I1
Aziz, SA; Bhat, GM; Changal, KH; Lone, AR; Mir, MH1
Antón-Aparicio, L; Aparicio-Gallego, G; Blanco, M; Figueroa, A; García-Campelo, R; Grande-Pulido, E; Valladares-Ayerbes, M1
Robert, C1

Reviews

3 review(s) available for pyrroles and Incontinentia Pigmenti Achromians

ArticleYear
[Pigmentary disorders induced by anticancer agents. Part II: targeted therapies].
    Annales de dermatologie et de venereologie, 2013, Volume: 140, Issue:4

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Cetuximab; Dasatinib; ErbB Receptors; Humans; Imatinib Mesylate; Indazoles; Indoles; Ipilimumab; Niacinamide; Phenylurea Compounds; Pigmentation Disorders; Piperazines; Piperidines; Programmed Cell Death 1 Receptor; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Quinazolines; Receptors, Vascular Endothelial Growth Factor; Sorafenib; Sulfonamides; Sunitinib; Thiazoles

2013
New insights into molecular mechanisms of sunitinib-associated side effects.
    Molecular cancer therapeutics, 2011, Volume: 10, Issue:12

    Topics: Animals; Antineoplastic Agents; Carcinoma, Renal Cell; Drug-Related Side Effects and Adverse Reactions; Humans; Hypertension; Hypothyroidism; Indoles; Kidney Neoplasms; Models, Biological; Pigmentation Disorders; Pyrroles; Signal Transduction; Sunitinib

2011
[Cutaneous side effects of antiangiogenic agents].
    Bulletin du cancer, 2007, Volume: 94 Spec No

    Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzenesulfonates; Bevacizumab; Drug Eruptions; Humans; Indoles; Niacinamide; Phenylurea Compounds; Pigmentation Disorders; Pyridines; Pyrroles; Skin Diseases; Sorafenib; Sunitinib

2007

Other Studies

3 other study(ies) available for pyrroles and Incontinentia Pigmenti Achromians

ArticleYear
Images in clinical medicine. Sunitinib-associated hair depigmentation.
    The New England journal of medicine, 2014, Apr-24, Volume: 370, Issue:17

    Topics: Adult; Antineoplastic Agents; Female; Hair; Humans; Indoles; Pigmentation Disorders; Pyrroles; Sunitinib; Thymoma; Thymus Neoplasms

2014
Yellowish nail pigmentation caused by sunitinib.
    International journal of dermatology, 2016, Volume: 55, Issue:8

    Topics: Aged; Carcinoma, Renal Cell; Female; Follow-Up Studies; Humans; Indoles; Kidney Neoplasms; Nail Diseases; Pigmentation Disorders; Pyrroles; Risk Assessment; Sunitinib

2016
Sunitinib in metastatic renal cell carcinoma (mRCC): a developing country experience. Do our patients behave differently than the Western patients?
    International urology and nephrology, 2016, Volume: 48, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Agents; Carcinoma, Renal Cell; Developing Countries; Disease-Free Survival; Fatigue; Female; Follow-Up Studies; Hand-Foot Syndrome; Humans; India; Indoles; Kidney Neoplasms; Male; Middle Aged; Mucositis; Niacinamide; Phenylurea Compounds; Pigmentation Disorders; Prospective Studies; Pyrroles; Response Evaluation Criteria in Solid Tumors; Sirolimus; Sorafenib; Sunitinib; Survival Rate; White People; Young Adult

2016